Psychedelics
Many currently or formerly controlled substances, such as MDMA, psilocybin, cannabis, ketamine, LSD and others, have shown immense promise as therapeutic treatments for a range of mental health disorders. Here's the latest research and findings in psychedelic and next-gen medicine.
Top News
-
An effective single-dose, long-term treatment for anxiety could be within reach, with the phase 2b clinical trial of MM-120 reported to have passed the stage with flying colors. -
Researchers have revealed how regular ketamine use produces divergent changes in parts of the brain that produce the ‘feel-good’ neurotransmitter, dopamine. The discovery could have significant implications for the treatment of mental illness. -
While CBD or cannabidiol is now widely available, widely used and generally considered safe, new research has found its use during pregnancy may produce some strange behavior in offspring and changes to the way their brains process sensory information.
Load More
Latest News
-
September 22, 2024After comparing the long-term effects of the psychedelic psilocybin and a commonly prescribed antidepressant, new research found that both significantly reduced depression. However, psilocybin provided something more: a significant boost to quality of life. -
September 13, 2024A poll of Americans aged 50 and over on their use of cannabis has provided some interesting insights into how often they use the drug, how and why they use it, and the behaviors they engage in while under the influence. -
August 15, 2024We were this close to seeing Ecstasy being incorporated into therapy in the US in 2024. Now, we have to wait either a little or a lot – depending on how the chips fall. Let's have a closer look at where we're currently at. -
July 02, 2024Citizen scientists have been key to the discovery of two new species of hallucinogenic fungi, joining the ranks of 140 known types of these psychoactive mushrooms. One even has longstanding roots in traditional healing medicine in mountainous Lesotho. -
June 24, 2024A slow-release, twice-a-week ketamine tablet significantly reduced depression symptoms, according to the results of a clinical trial. The tablet can be taken at home without medical supervision, making it more convenient than current ketamine treatments. -
March 19, 2024Laws are opening up to support the use of medicinal psilocybin – and that requires new technology to ensure accurate, consistent dosing. Researchers have now developed a fast and reliable method of determining the potency of magic mushrooms. -
February 19, 2024New research has found that daily users of crystal methamphetamine who turned to cannabis to manage their cravings used the stimulant drug less, especially female users. The findings suggest a new harm-reduction strategy is needed. -
February 08, 2024A study has found that a cannabis extract can inhibit the growth of melanoma cells and trigger cell death. The next step is pre-clinical trials to investigate whether the extract can be used to treat other types of cancers. -
January 16, 2024Researchers have uncovered a brain mechanism that causes 'the munchies' after cannabis use, paving the way for therapeutics to treat appetite disorders like anorexia and obesity and to improve the appetite of patients undergoing cancer treatment. -
January 15, 2024A new study has found that there was no association between using cannabis and non-medical opioid use in people receiving pharmacotherapy for opioid use disorder. The findings neither confirm that using cannabis leads to opioid use nor that it's effective in reducing it. -
December 18, 2023A clinical trial has demonstrated that psilocybin-assisted therapy is effective at treating depression in patients with cancer. In a first, the drug was given to small groups of patients simultaneously, before they underwent one-on-one and group therapy. -
November 13, 2023A new study has found that a majority of medical cannabis users suffering from insomnia and poor-quality sleep are ditching conventional over-the-counter and prescription sleep aids in favor of using the drug to treat sleep-related problems. -
October 19, 2023A study into using ketamine to treat depression has yielded surprising results. Despite the unique way in which the researchers ensured the trial was ‘blind’, the placebo and treatment groups had the same improvement in symptom severity. -
October 05, 2023Researchers have found that treating Special Ops veterans with psychedelics improved their mental health and, unexpectedly, their cognitive functioning, underscoring the benefits of psychedelic therapy for those with complicated trauma histories. -
September 06, 2023A study into the effects of medicinal cannabis on the health of people living with chronic illnesses has found that the drug significantly improves health-related quality of life, fatigue, pain, anxiety, and depression.
Load More